JPRN-UMIN000005071已完成未知
Study of efficacy and safety of oral neurokinin-1 antagonist, aprepitant for prevention of chemotherapy-induced nausea and vomiting associated with 5-FU/cisplatin chemotherapy in patients with head and neck cancer. - Effect of aprepitant in patients with head and neck cancer receiving 5-FU/cisplatin chemotherapy.
Department of otolaryngology , Nagasaki University Hospital0 个研究点目标入组 20 人开始时间: 2011年2月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patient has a serious hepatic insufficiency or renal failure 2) Patient has nausea or vomiting within 24 hours prior to chemotherapy 3) Patient has been treated with antiemetic agents within 48 hours prior to chemotherapy 4) Patient has any illness (e.g. central nervous system tumors, gastrointestinal obstruction, active peptic ulcer, brain metastasis) caused nausea or vomiting except for chemotherapy-induced nausea and vomiting 5) Patient is scheduled to receive radiation therapy to the abdomen 6) Patient is judged inappropriate by the investigator as subject for this study
研究者
相似试验
招募中
不适用
Study of oral neurokinin-1 antagonist, aprepitant for the prevention of nausea and vomiting in patients receiving chemotherapy with irinotecan alone or combination of irinotecan plus cisplatin for unresectable gastric cancergastric cancerJPRN-UMIN000004021Division of Upper Gastroenterology, Department of Internal Medicine, Hyogo College of Medicine80
招募中
不适用
Effect of oral neurokinin-1 antagonist, aprepitant for chemotherapy-induced nausea and vomiting in patients with gynecologic cancer receiving carboplatin/paclitaxel chemotherapy.JPRN-UMIN000005317Department of gynecology, Fukuoka University Hospital60
已完成
不适用
Effectiveness and safety of oral and intralesional tranexamic acid in treatment of melasmaCTRI/2021/08/035350Department of Dermatology42
已完成
1 期
Phase Ia Safety and Pharmacokinetic Study of Oral NV-196 in Patients with Solid TumoursACTRN1260600034558312
已完成
3 期
Efficacy of N-acetylcysteine in patients with COVID-19covid-19.COVID-19U07.1IRCT20200623047897N1Iran University of Medical Sciences60